Article Image
News Link • Science, Medicine and Technology

Update on Oison Biotech key part of SENS antiaging research

• Author: brian wang

The Oisin technology is highly adaptable, and can be programmed to kill any class of cell that has some distinct internal marker in the form of high levels of expression of a specific protein. The founders started with senescent cells based on the p16 marker, but as this latest interview with Gary Hudson makes clear, have expanded their efforts to effectively target cancer with p53, and beyond that they are really only limited by time, funding, and a good map of the internal biochemistry of the target cell type. The sky is the limit in the long term: any type of cell that is undesirable should have some distinctive chemistry that can be attacked, and there are many possible targets.

This update is from The writer of Fightaging is also invested in the Oisin company.

Join us on our Social Networks:


Share this page with your friends on your favorite social network: